网膜素1与代谢内分泌疾病关系的研究进展
摘要
传统观念认为脂肪组织仅仅是储存机体能量的场所,随着近些年研究的不断深入,其活跃的内分泌功能逐渐被发掘,其所分泌的如瘦素、脂联素、网膜素、内脂素等脂肪因子通过内分泌、旁分泌和自分泌途径广泛参与调节机体诸多生理功能.
出处
《河北医科大学学报》
CAS
2013年第3期364-367,共4页
Journal of Hebei Medical University
参考文献18
-
1DE SOUZA BAT1STA CM, YANG RZ, LEE MJ, et al. Omentin plasma levels and gene expression are decreased in obesity [ J ]. Diabetes,2007,56 (6) : 1655 - 1661.
-
2PAN HY,GUO L,LI Q,et al. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes [ J]. Diabetes Res Clin Pratt,2010,88 ( 1 ) :29 - 33.
-
3YAMAWAKI H, TSUBAKI N, MUKOHDA M, et al. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels [ J ]. Biochem Biophys Res Commun, 2010,393 (4) : 668 - 672.
-
4TAN BK,ADYA R, RANDEVA HS, et al. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease [ J ]. Trends Cardiovasc Med,2010,20 (5) : 143 - 148.
-
5MAHDE A, SHAKER M, AL-MASHHADANI Z, et al. Study of omentin-1 and other adipokines and hormones in PCOS patients [ J]. Oman Med J,2009,24(2) : 108 - 118.
-
6YANG RZ,LEE M J, HU H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue:possible role in modulating insulin action [ J ]. Am J Physiol Endocrinol Metab,2006,290(6 ) : E1253 - 1261.
-
7SCHAFFLER A, NEUMEIER M, HERFARTH H, et aL Genomic structure of human omentln, a new adipocytokine expressed in omental adipose tissue [ J ]. Biochim Biophys Acta, 2005,1732 (1/3) :96 -102.
-
8蔡润策,魏丽,狄建忠,于浩泳,包玉倩,贾伟平.肥胖和2型糖尿病患者脂肪组织网膜素的mRNA表达[J].中华医学杂志,2009,89(6):381-384. 被引量:42
-
9MORENO-NAVARRETE JM, CATALAN V, ORTEQA F, et al. Circulating omentin concentration increases after weight loss J. Nutr Metab(Lond) ,2010,7:27.
-
10TAN BK, ADYA R, FARHATULLAH S, et al. Omentin-1, a novel adipokine,is decreased in overweight insulinresistant women withpolycystic ovary syndrome: ex vivo and in vivo regulation of omentin-I by insulin and glucose [ J ]. Diabetes, 2008,57 ( 4 ) : 801 - 808.
二级参考文献22
-
1Looker HC, Knowler WC, Hanson RL, et al. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care, 2001,24: 1917-1922.
-
2Trayhurn P, Beattie JH. Physiological role of adipose tissues : white adipose tissues as an endocrine and secretory organ. Proc Nutr Soc, 2001, 60: 329-339.
-
3Schaffler A, Neumeier M, Herfarth H, et al Genomie structure of human omentin, a new adipocytokine expressed in omental adipose tissue. Biochim Biophys Acta, 2005, 1732: 96-102.
-
4Yang RZ, Lee MJ, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 2006, 290: 1253-1261.
-
5de Souza Batista CM, Yang RZ, Lee MZ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes, 2007, 56: 1655-1661.
-
6Yang RZ, Xu A, Pray J, et al. Cloning of omentin,a new adipocytokine from omental fat tissue in human[J]. Diabetes 2005, 52= A1.
-
7Doyle ME, Egan JM. Mech&nisms of action of glucagon-lfke peptide ] in the p&ncre&s[J]. Pharmacology & Therapeutics, 2007 3: 546-595.
-
8Holz G G,Leech C A,Helier R S,et al .cAMP-dependent mobilizatfon of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells.A Ca2+signal?ng system stimulated by the insulinotropic horm one glucagons-like peptide 1 (7-37)[J]. J Bio Chem, 1999, 274: ;4147- 14156.
-
9Touel C, bailbe Lacorne M. Persistent improvement of type 2 diabetes in the Goto.Kakizaki rat model by expan sion of the beta cell massduring the prediabetic period with gfucagons-lfke peptide-1 or exendin-4[J]. Diabetes,2002, 51: 1445-1452.
-
10Mafong DD, Henry El&. The role of incretins in cardiovascular control[J]. Curt Hypertens gep, 2009, 11: 18-22.
共引文献46
-
1矫磊,刘金波,凌明英,曹立君,侯新国,孙宇,李振作,尹小芳,张亮,范琳琳,陈丽.网膜素-1、内脂素与新诊断2型糖尿病患者动脉粥样硬化的相关性[J].山东大学学报(医学版),2010,48(1):8-11. 被引量:27
-
2曾俊,杨刚毅.脂肪细胞因子与胰岛素抵抗的关系及其机制研究新进展[J].成都医学院学报,2011,6(1):78-82. 被引量:18
-
3陈茜,牛建民,温济英,雷琼.脂肪细胞因子网膜素-1与代谢综合征[J].实用医学杂志,2011,27(10):1887-1889. 被引量:2
-
4张秀娟,刘礼斌.新型脂肪细胞因子网膜素的研究进展[J].医学研究杂志,2011,40(8):26-28. 被引量:1
-
5吕韶燕,单体栋,田林红.网膜素与2型糖尿病的相关性研究[J].现代生物医学进展,2012,12(1):189-191.
-
6李健,余兰.糖尿病视网膜病变患者血浆网膜素的变化及其相关因素[J].中国老年学杂志,2012,32(8):1594-1595. 被引量:9
-
7赵姜,田凤石,雒瑢.替米沙坦对改善OLETF大鼠胰岛素抵抗作用的探讨[J].天津医药,2012,40(6):605-608. 被引量:2
-
8吕攀攀,瞿平,毕杨,陈洁,张蔓,刘友学.高脂饲料诱导的肥胖大鼠网膜素水平的实验研究[J].生命科学研究,2012,16(2):144-148. 被引量:2
-
9赵力,李田昌.网膜素的研究进展[J].国际心血管病杂志,2012,39(3):160-163. 被引量:6
-
10傅绪栋.2型糖尿病患者血清淀粉样蛋白A及内脂素水平与颈动脉内膜中层厚度的关系[J].中国老年学杂志,2012,32(16):3396-3398. 被引量:5
-
1卢世梅.糖尿病的营养治疗及其观察[J].中华临床医学杂志,2006,7(5):58-59.
-
2马秀丽.糖尿病合并肺结核的护理体会[J].山东医药,2003,43(5):65-66. 被引量:25
-
3江钟立.糖尿病的康复治疗[J].中华物理医学与康复杂志,2007,29(7):498-500. 被引量:6
-
4王宪景,潘淑萍,潘淑文.活血化瘀法治疗糖尿病慢性并发症初探[J].黑龙江中医药,2005,34(1):5-7.
-
5汪建民.抗结核药物对糖尿病患者肝功能的影响[J].中国临床医学,2002,9(6):742-743. 被引量:2
-
6刘景泉.美迪康治疗2型糖尿病临床疗效研究[J].实用心脑肺血管病杂志,2011,19(3):387-387.
-
7吴坚可,梁铁美,傅军霞.降血糖药的种类及其不良反应[J].现代中西医结合杂志,2006,15(9):1184-1185. 被引量:1
-
8张现峰,雷惠新.脂联素与缺血性脑血管病的相关性研究进展[J].中西医结合心脑血管病杂志,2009,7(11):1330-1332. 被引量:1
-
9张金萍,王立恒.糖尿病合并肺结核的护理[J].局解手术学杂志,2008,17(2):136-137. 被引量:1
-
10刘正元.瑞格列奈联合二甲双胍缓释片治疗2型糖尿病30例临床观察[J].中国农村卫生,2013(04Z):200-200.